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Abstract 
Lamin-associated polypeptides (LAPs) comprise inner nuclear membrane proteins 
tightly associated with the peripheral lamin scaffold as well as proteins forming stable 
complexes with lamins in the nucleoplasm. The involvement of LAPs in a wide range 
of human diseases may be linked to an equally bewildering range of their functions, 
including sterol reduction, histone modification, transcriptional repression, and Smad- 
and β-catenin signaling. Many LAPs are likely to be at the center of large multi-
protein complexes, components of which may dictate their functions, and a few LAPs 
have defined enzymatic activities. Here we discuss the definition of LAPs, review 
their many binding partners, elaborate their functions in nuclear architecture, 
chromatin organization, gene expression and signaling, and describe what is currently 
known about their links to human disease. 
 
Introduction 
The eukaryotic nucleus is a complex organelle with essential functions in genome 
stability, DNA replication and gene expression. It is structurally and functionally 
organized into distinct sub-compartments, most prominently the nuclear envelope 
(NE), which separates nuclear and cytoplasmic activities. The NE is comprised of 
three major structures (Fig. 1) [1,2]: i) two concentric membrane layers, the outer 
(ONM) and the inner (INM) nuclear membrane facing the cytoplasm and 
nucleoplasm, respectively, and separated by the perinuclear lumen; ii) nuclear pore 
complexes (NPCs) inserted into the double membrane, which mediate nucleo-
cytoplasmic exchange of components, and iii) the nuclear lamina protein meshwork 
that is tightly associated with the INM and provides mechanical stability.  The ONM 
is directly linked to and functionally related to the endoplasmic reticulum (ER) and 
thus contains ribosomes and other ER proteins. Yet a subset of ONM proteins is 
unique and not shared with the ER. The INM (although joined with the ONM at 
NPCs) contains its own unique group of integral membrane proteins that selectively 
and efficiently target to the INM [3,4]. Many of these INM proteins are components 
of the nuclear lamina, the core of which is formed by the nuclear-specific, type V 
intermediate filament lamin proteins. Details of lamins are covered elsewhere in this 
issue; however, critical to this review is that there are different lamin subtypes: B-type 
lamins expressed throughout development, and A-type lamins found predominantly in 
differentiated cells [5,6]. Lamins are post-translationally modified by farnesylation 
[7]. B-type lamins are permanently farnesylated and thus tightly associated with the 
INM, in contrast with A-type lamins that either are not farnesylated at all or have the 
farnesyl group removed by an additional post-translational proteolytic cleavage of the 
C-terminal 15 residues. The transient farnesylation of lamin A may facilitate its 
incorporation into the lamina, but after cleavage it should be less tightly associated 
with the membrane and accordingly, a subfraction of lamin A (estimated at ~5 to 
10%) can also be found in the nuclear interior [8]. Multiple stable interactions of 
lamins with INM proteins within the nuclear lamina are fundamental for the 
mechanical integrity of the NE. This review focuses on mammalian lamin-associated 
proteins, most of which are components of the NE and the lamina. We attempt to 
resolve confusion between the terms lamin-versus lamina-associated polypeptides, 
which have been synonymously used in literature, and describe interactions, dynamics 
and potential functions of the best studied lamin-associated polypeptides in mammals, 
as well as their potential involvement in human diseases.    
 
Definition of LAPs as lamin-associated polypeptides 
The term LAP was originally used to designate “lamina-associated polypeptides”, 
INM proteins stably associated with the lamina at the nuclear periphery. These 
proteins bound lamins and cofractionated with lamins upon extraction with buffers 
containing high concentrations of monovalent salts and non-ionic detergents [9,10]. 
As the lamina is restricted to the nuclear periphery, LAPs by this definition are 
located at the NE. However, thereafter the term LAP has also been used for lamin-
associated polypeptides, including proteins associated with the ~5% of lamins not 
located at the nuclear periphery. As the intranuclear lamins are presumably not 
assembled into a filamentous structure like in the lamina, epitopes may be accessible 
in nucleoplasmic lamins that are masked in filaments and thus enable interactions 
with a different set of binding partners. In both cases, however, the term “associated” 
is meant to indicate a stable or protracted interaction with lamins or lamin complexes 
biochemically defined by resistance to extraction with salt and detergent. In contrast 
proteins that interact with lamins transiently upon activation of specific signaling 
pathways or during the cell cycle or differentiation would be referred to as lamin-
interacting polypeptides. In this review we use the more general definition of LAPs 
defining proteins stably associated with peripheral and internal lamin complexes. One 
aspect of this biochemical definition of LAPs is that the interaction with lamins can 
also be indirect. A LAP could bind another LAP that binds to lamins and still resist 
the harsh extraction conditions.  
 
Clearly defined LAPs 
LAP1 and LAP2 (now known as LAP2β) were identified by monoclonal antibodies 
generated against lamina-enriched fractions of rat liver nuclei [9,10]. Both proteins 
were determined to be integral membrane proteins by biochemical means and to 
reside at the NE and INM by immunofluorescence and immunogold electron 
microscopy. Moreover, they bound lamins in vitro. Thus LAPs 1 and 2 have all the 
characteristics of the most stringent definition of a LAP, although they showed quite 
different extractabilities at different salt concentrations [9]. The antibody to LAP1 
recognized three proteins designated LAP1A, B and C, and cloning of LAP1C [11] 
indicated that these forms are derived by alternative splicing and expressed in a 
developmentally regulated manner. Co-precipitation confirmed binding of LAP1C to 
lamin B [12], but the other LAP1 variants have not been analyzed further. Analysis of 
the human genomic sequence indicates that the LAP1 gene may have a plenitude of 
splice variants but this has not been followed up yet.  
Much more has been revealed on the LAP2 proteins since their initial 
identification. Cloning of the rat, mouse and human cDNAs and genes [13,14,15,16] 
identified 6 alternatively spliced isoforms LAP2α, β, γ, δ, ε, and ζ, all of which, 
except for LAP2α and ζ, contain a single C-terminal transmembrane domain and a 
long nucleoplasmic N-terminus [17]. The first described LAP2 antibodies recognized 
only LAP2β, the largest transmembrane LAP2 that binds preferentially lamin B 
[9,18]. The smaller isoforms, which lack specific regions in the nucleoplasmic 
domain, have yet to be tested for their lamin binding activity. LAP2α is unique, as it 
shares only the N-terminal third with the other isoforms and contains a distinct large 
C-terminus without a transmembrane domain. Accordingly LAP2α localizes to the 
nuclear interior [19], where it forms stable complexes with A-type lamins [20]. 
Although LAP2α is resistant to detergent/salt extraction [19] and binds lamins it 
clearly is not a lamina-associated protein as it is not part of the peripheral lamina. It 
represents an example of a lamin-associated protein that forms stable and protracted 
complexes with lamins outside the lamina.  
Database searches have revealed a 40 amino acid-long motif of two helices 
[21] termed the LEM domain (for LAP2, Emerin and MAN1) that is shared by LAP2 
isoforms, MAN1, emerin [22,23], LEM2/NET25 [24,25], and three uncharacterized 
proteins LEM3-5 in mammals [26]. The LEM domain binds the chromatin protein 
BAF (Barrier to autointegration Factor; [27,28,29]. Although LEM-domain proteins 
have no sequence similarity outside the LEM domain and contain different numbers 
of predicted transmembrane domains, all tested localize to the NE and bind lamins 
[24,30,31,32,33]. Moreover, emerin [34,35] and LEM2 [24] require A-type lamins for 
localization in the INM.   
The lamin B-receptor (LBR) is another well-studied INM protein, identified 
by a biochemical screen for lamin-binding proteins in a lamin-depleted NE fraction 
[36]. LBR preferentially bound to lamin B over lamin A, was shown to have similar 
resistance to extraction with 0.1 M NaOH or 8 M urea, and antibodies yielded nuclear 
rim staining. LBR is solubilized only in highly stringent conditions and can thus also 
be considered a lamina-associated polypeptide. Cloning and further analyses have 
shown that LBR is a polytopic protein with eight potential transmembrane domains 
[37]. 
 Since these initial studies on LAPs 1 and 2 and LBR, around 80 additional 
putative NE transmembrane proteins have been identified (reviewed in [4]). Almost 
all of the potential LAPs tested thus far have been shown to target to the NE and those 
that have passed the criteria for inclusion as LAPs are shown in Table 1.  
SUN1 [38,39,40] and SUN2 [41,42] are INM proteins containing a Sad1-UNC 
homology domain (SUN) that extends into the perinuclear space and interacts with 
ONM proteins termed nesprins [43,44]. The latter proteins form a huge family of 
isoforms encoded by three genes, Nesprin 1, 2, and 3, but many isoforms are localized 
on different cellular membranes, including mitochondria. Nevertheless, many of them 
target to the ONM and bind SUN domain proteins and some of them, such as nesprin 
2 isoforms even localize to the INM and bind lamins [45] or their localization 
depends on lamin A [46]. 
A caveat of the above-mentioned definition of LAPs is that NPCs co-isolate 
with the lamina fraction and share some biochemical characteristics with lamina 
components. GP190/POM121, GP210, and NDC1/NET3 were also shown to localize 
to the NE, were resistant to extraction with Triton X-100, and were retained in 
membrane vesicles in the presence of chaotropes [47,48,49]. Yet these would not be 
considered LAPs because they are integral proteins of the NPC. 
 
LAPs function as assembly points for multi-protein complexes 
Most LAPs have been characterized in terms of their interactions. An LBR-complex 
was found in chicken erythrocytes that contains an LBR-specific kinase, p32, and an 
18 kDa protein of the INM and ONM [50,51,52]. A second LBR complex has at its 
core an interaction with heterochromatin protein 1 alpha and gamma (HP1; [53,54]) 
and also contains histones H3/H4 [55] and epigenetically marked heterochromatin 
[56]. Interactions within this complex are likely epigentically regulated, as histone 
deacetylase inhibitors impaired the transient accumulation of microinjected HP1 at 
the NE [57]. 
A multitude of interactions have also been found for LEM proteins: first is 
their interaction with the DNA- and histone-binding protein barrier to autointegration 
factor (BAF) [28,58] that has essential functions in chromatin organization and gene 
regulation [59]. Biochemical and structural studies have identified the LEM domain 
in LAP2β to mediate the interaction with BAF [27,29] and binding of BAF to other 
LEM proteins has been experimentally confirmed for MAN1 [32], emerin [31] and 
LAP2α [60]. Thus, all LEM domain proteins can bind chromatin via BAF. Moreover, 
some have additional interactions with chromatin. MAN1 has a second BAF-binding 
region outside its LEM domain [32] and a predicted DNA binding winged Helix C-
terminal domain [61]. A second LEM-like motif at the N-terminus of all LAP2 
proteins interacts with DNA [27] and LAP2β additionally binds DNA and chromatin 
protein HA95 via C-terminal isoform-specific regions [62,63].  
Furthermore, several LEM proteins have been found to bind to different 
regulatory proteins, including the transcriptional repressor germ cell-less [32,64], 
transcriptional repressor Btf [32,65], transcriptional regulator Lmo7 [66], splicing 
factor YT521-B [67], epigenetic modifier enzymes [68], and signaling molecules (see 
below), indicating that lamin-LAP complexes can serve as scaffold structures, 
regulating gene expression and signaling pathways.  
There is evidence that different LAP complexes may be segregated at the NE. 
LBR-lamin B-containing complexes are excluded from LEM protein-lamin A 
microdomains formed in LEM2 expressing cells [24]. Similarly a lamin mutant that 
redistributed lamin subtypes into distinct microdomains correspondingly redistributed 
LAPs known to bind each lamin subtype [69]. 
The fact that many LAP interaction partners were found in different cell types 
suggests that LAPs may have a wider range of binding partners that are tissue-
specific. Tissue-specific LAP-complex formation may be regulated by the availability 
of potential binding partners in a specific cell type, the relative abundance of both 
LAPs and binding partners, and their relative affinities (Fig. 2). Further evidence that 
some LAPs are at the center of large tissue-specific complexes comes from a recent 
study on epitope masking at the NE. Six different monoclonal antibodies to different 
epitopes of emerin were generated, each of which recognizes the protein by 
immunofluorescence in some cell types. However, none recognized emerin in spleen, 
even though it was clearly present by Western blot analysis [70] suggesting that all 
six epitopes are masked by binding partners. Such an extreme degree of epitope 
masking is consistent with the large number of identified binding partners that 
associate with distinct and/or overlapping regions of the emerin protein [71]. A 
parallel result was obtained for lamin B1. Three different lamin B1 antibodies were 
used to stain heart and hippocampus sections: one stained just cardiomyoctyes, 
another stained just hippocampus, and the third stained both [70]. As each antibody 
recognized a different region, different partners may occupy different binding sites in 
the different tissues. These data suggest that LAPs and lamins form large tissue-
specific multiprotein complexes, the perturbation of which may underlie tissue-
specific phenotypes in lamin-linked diseases (see below).  
 
LAP-complexes function in nuclear architecture  
Among the original LAPs studied, only one had a clearly determined enzymatic 
activity. The C-terminus of LBR is homologous to yeast sterol C-14 reductase 
(Erg24p; [72]) and the human gene can functionally complement a yeast Erg24p 
mutant [73]. All other functions reported for LAPs are structural ones involved in 
nuclear architecture and higher order chromatin organization, and in providing 
scaffolds for gene regulatory and signaling complexes (Fig. 3).   
Given the structural roles of cytoplasmic intermediate filament proteins, it is 
not surprising that their nuclear counterparts, the lamins together with LAPs are to a 
large extent providing mechanical support for the NE [69,74,75]. The relevance in 
nuclear architecture has been demonstrated for several LAPs. Lower expression levels 
of LBR, as seen in LBR-associated diseases affect nuclear shape and chromatin 
organization in blood granulocytes [76]. Emerin-deficient cells have normal structural 
integrity but impaired mechanotransduction [77] and knockdown of LEM2 leads to 
abnormally shaped nuclei [78]. Functional redundancy of LEM proteins in 
mammalian cells is most likely the reason for only mild phenotypes typically 
observed with single LEM-protein deficiencies. In C.elegans, only the simultaneous 
downregulation of the major LEM proteins, Ce-emerin and Ce-lem2 (formerly 
referred to as Ce-MAN1), caused severe chromatin organization phenotypes [79].  
A structural link between the nucleoskeleton and cytoskeleton across the NE is 
provided by the INM SUN domain proteins, which form dimers and interact with 
ONM nesprins that in turn associate with the cytoskeletal filament systems (Fig. 3; for 
review see [80]). In C. elegans these proteins were linked to nuclear positioning and 
migration [43]. Transgenic mice overexpressing a dominant negative nesprin/syne-1 
fragment exhibited impaired anchorage of nuclei at neuromuscular junctions [81], 
indicating that this function is evolutionarily conserved. The SUN-nesprin complex 
may also be involved in regulating the space between INM and ONM, since 
downregulation of SUN1 and 2 in HeLa cells caused detachment of the ONM and 
extension of the perinuclear space [38]. 
 
LAP-complexes function in chromatin organization 
Given the numerous interactions of LAPs with chromatin proteins and DNA, it is 
plausible that they are involved in higher order chromatin structure (Fig. 3). LBR 
interactions with heterochromatin determinants [54,56], and LEM protein interactions 
with the DNA-crosslinking BAF [59] argue for a role of LAPs in forming 
heterochromatic regions. In support of this LAP2β binds HDAC3 that mediates H4 
deacetylation [68], linked to heterochromatic, transcriptionally inactive genomic 
regions. Since most LEM proteins have been shown to bind BAF they may be 
functionally redundant. However, most of the other interaction partners of LEM-
domain proteins bind outside the conserved LEM domain, suggesting also 
considerable specificity in the functions of these proteins. 
LAP-chromatin interactions may also be important for nuclear assembly after 
mitosis. LBR is among the first proteins to assemble around sister chromatids in 
anaphase [82,83]. Its immunodepletion from cell lysates impaired in vitro NE 
assembly [84], suggesting that LBR is a key component for targeting membranes to 
chromosomes. LAP2β was suggested to be important for NE enlargement in G1 
phase, because LAP2β fragments in Xenopus nuclear assembly reactions [85] or 
microinjected into mitotic mammalian cells [86] blocked nuclear growth in G1-S-
phase. More recently, a basic domain in LAPs was suggested to mediate binding of 
INM proteins to negatively charged DNA during the initial docking of membranes 
[87]. This domain is a basic (pI > 8.5) nucleoplasmic region of more than 100 amino 
acid residues found in 46% of putative nuclear envelope proteins recently identified 
[25]. However, more specific targeting and assembly pathways have to be involved as 
well, since LBR and LAP2 bind different chromatin regions during assembly. LAP2α 
initially is targeted to telomeres in anaphase and further assembles to chromatin-
associated “core structures” in telophase [60]. The chromatin-bound core structures, 
located adjacent to the mitotic spindle, contain also emerin, LAP2β, and BAF, while 
LBR complexes bind equatorial regions of anaphase chromatin [60,83]. The 
complexes at the core regions were determined to be stable by FRAP (fluorescence 
recovery after photobleaching) [88] and important for NE assembly because emerin, 
LAP2α, and BAF mutants that disrupted LAP-BAF interactions failed to assemble 
NEs in vivo and in vitro [89,90].  
 
LAP-complexes function in gene expression and signaling 
LAPs may affect gene expression by epigenetic mechanisms and by binding to 
repressor proteins or sequestering transcription factors (Fig. 3). LAP2β binds the 
repressor germ cell less (gcl), which is known to affect E2F/DP transcription factor 
heterodimers [64]. Emerin also interacts with gcl [91], and with the repressor Btf [65]. 
The binding of LEM-domain proteins with BAF could similarly influence gene 
regulation, as BAF has been found to repress gene expression in retinal cells via 
binding to the homeodomain transcription factor Crx [92]. Furthermore, pull-down 
studies identified an emerin-binding transcription factor, Lim domain only (Lmo7), 
which controls the expression of emerin and many muscle specific genes [66]. Since 
overexpression of emerin inhibited Lmo7, the Lmo7-emerin interaction is tightly 
regulated by feedback pathways. Finally, LAP2α-lamin A complexes in the nuclear 
interior bind the tumor supressor retinoblastoma (Rb) [93], which is a negative 
regulator of E2F-dependent transcription controlling the balance between 
proliferation and differentiation [94]. Accordingly LAP2 can associate with E2F/Rb-
responsive promoters and impair expression of E2F-target genes upon cell cycle exit 
and differentiation [95].   
Novel data point towards a function of LAPs in signaling. Mammalian MAN1 
binds Receptor-Smads 2/3, downstream effectors of the TGFβ and bone morphogenic 
protein (BMP) signaling cascades [96]. MAN1 overexpression impaired Smad 2/3 
phosphorylation, heterodimerization (with Smad 4), and nuclear translocation - events 
that are linked to an active pathway – and thus antagonizes signaling [97]. Given the 
ubiquitous expression of MAN1, the physiological relevance of MAN1 in TGFβ and 
BMP signaling is unclear: MAN1 could either recruit and de-activate Smads as a 
mechanism to eliminate weak signals, or alternatively, MAN1 might have a major 
role in regulating Smad signaling only in a subset of tissues due to the presence of 
additional tissue-specific MAN1 binding partners. 
Emerin may also have signaling functions as it interacts with β-catenin, a dual 
function protein in cell-cell adhesion and transcriptional activation. Overexpression of 
emerin causes cytoplasmic accumulation of β-catenin, leading to the inhibition of its 
transcriptional activity. Conversely, emerin-null cells have increased nuclear, 
transcriptionally active β-catenin [98].   
 
How do INM LAPs reach their destination? 
In theory, for LAPs to access the INM they must either (1) diffuse laterally in the 
membrane around the outside of the NPCs; (2) bud off of the ONM as vesicles into 
the lumen of the NE, then fuse again with the INM; or (3) be removed from the ER 
membrane, maintained in a soluble form during transport through the NPC, and re-
inserted into the membrane inside the nucleus (Fig. 1). The latter two mechanisms 
would be energetically unfavorable and have little or no support in the literature. The 
first mechanism obtained its support initially from studies, in which fusions of the 
nucleoplasmic region of LBR to the membrane-spanning segment of a ER/plasma 
membrane protein resulted in its targeting to the INM [99], while inserting an 
increasing mass of protein between the LBR nucleoplasmic region and the 
transmembrane segment resulted in the fusion protein no longer being able to access 
the INM [100]. It was proposed that the limited space between the membrane and the 
body of the NPC would set a size limit for the diffusion of the nucleoplasmic region 
in the membrane. Once in the nucleus, the nucleoplasmic LBR domain could be 
retained in the NE by binding to lamin B [101] and become immobile as shown by 
FRAP analysis [82]. 
More recent studies have demonstrated that transport is more complex, 
involving an energy-dependent gated mechanism. Ohba and colleagues developed a 
system for testing inducible INM accumulation of a protein [102].  They fused the 
LAP2β membrane-spanning segment to both GFP and FRB, and fused the lamin-
binding LAP2β nucleoplasmic region to FKBP. Upon addition of rapamycin, FRB 
binds to FKBP so that the lamin-binding region of LAP2β fuses to the integral 
membrane component. In agreement with the lateral diffusion-retention model, the 
membrane-spanning piece diffused at equilibrium between the ER and INM in the 
absence of rapamycin, but rapidly accumulated in the INM upon rapamycin addition. 
Unexpectedly, temperature and ATP-depletion significantly reduced accumulation 
while inhibitors of vesicle fusion and of soluble transport across the NPC had no 
deleterious effect. These data strongly argue against vesicle fusion and soluble 
transport mechanisms, but support an active, energy-dependent transport along the 
membrane. A recent study in yeast reports the presence of nuclear localization 
sequences (NLS) in INM protein orthologues, which are essential for their transport 
into the nucleus via a karyopherin- and Ran-GTPase dependent pathway [103]. It 
remains to be seen whether karyopherin and Ran-GTPase mediate a gated in-
membrane lateral diffusion indicated for mammalian systems, or whether this 
represents a distinct mechanism.   
 
Impairment of LAP functions gives rise to human diseases 
Mutations in lamins, particularly the LMNA gene, were linked to a hetergeneous 
group of diseases, collectively termed laminopathies, that affect tissues ranging from 
muscle to fat, bone, and skin [104,105]. The molecular mechanism for how missense 
mutations in lamins give rise to the diverse phenotypes is poorly understood, but may 
involve disruption of functional protein complexes associated on LAPs [106]. This is 
supported by the observation that mutations in some LAP genes also give rise to 
laminopathy-type diseases.  
Emerin mutations cause the X-linked form of Emery-Dreifuss Muscular 
Dystrophy (EDMD), characterized by progressive muscle wasting, shortening of 
tendons, and heart and conduction system defects [23,107]. Most disease-causing 
mutations result in reduced levels of emerin [108]. When expressed, several mutants 
of emerin (S54F, P183H, P183T, and Del95-99) mislocalized to the cytoplasm [109]. 
Intriguingly, mutations in lamin A cause the autosomal type of EDMD [110] and 
similarly, the expression of some of these lamin A mutants (L85R, N195K, E358K, 
M371K, R386K, R453W, W520S, and R527P) also resulted in mislocalization of 
emerin [111]. This suggests that functional lamin-emerin complexes are lost by 
mutations in either protein. The disease-relevant functions of this complex are 
unknown, but gene-expression profiling on muscle biopsies from patients [112] and 
on emerin deficient mouse cells [113] suggest a defect in the Rb1-MyoD pathway, 
involved in muscle differentiation.  
 LAP2α is linked to a laminopathy-type dilated cardiomyopathy, and loss of 
LAP2α-lamin A binding was observed for the mutated protein in vitro [114]. This 
finding again argues that disease-causing mutations in lamin A and LAP2α impair the 
functions of the nucleoplasmic complex. Because LAP2α can regulate Rb function 
during differentiation [95], it was proposed that mutations in LAP2α may affect the 
differentiation of adult muscle stem cells, which may impair homeostasis and 
regeneration of heart muscle tissues in patients [106]. 
 Heterozygous loss-of-function mutations in MAN1 cause osteopoikilosis, 
Buschke-Ollendorff syndrome and melorheostosis, characterized by increased bone 
density [115]. The pathological phenotype may be caused by impairment of MAN1 
function in Smad signaling, which is important for bone development. Accordingly, 
mutated MAN1 was unable to antagonize Smad signaling like the wild type, and 
TGFβ/ Smad-responsive genes were upregulated in patient fibroblasts versus controls. 
 Heterozygous LBR mutations mostly resulting in reduced protein levels cause 
Pelger-Huet anomaly (PHA), an autosomal dominant syndrome characterized by 
abnormal nuclear shape and chromatin organization in blood granulocytes [76]. 
Homozygous individuals lacking LBR have varying degrees of developmental delays, 
epilepsy and skeletal abnormalities. LBR is also linked to autosomal recessive 
Greenberg’s skeletal dysplasia, characterized by lethal skeletal and visceral anomalies 
[116]. It is unclear, to what extent the loss of LBR sterol reductase activity or the 
impairment of LBR chromatin-organizing function contributes to the phenotype. 
 Nesprin/Syne-1 (SYNE1) is associated with autosomal-recessive cerebellar 
ataxia [117], characterized by impaired walking due to a lack of coordination of gait 
and limbs. Since a brain-specific Nesprin/Syne-1 splice variant localizes to the 
postsynaptic endocytotic zone of excitatory synapses, mutations may disrupt 
glutamate receptor turnover and function. Thus, this disease is likely not caused by 
defects in nuclear specific functions of Nesprin/Syne-1. 
 Finally, LAP1 has recently been linked to primary dystonia, a CNS-based 
autosomal-dominant movement disorder caused by mutations in the AAA+ATPase 
torsin A.  Normally, ATP bound torsin A is recruited to the NE by LAP1, while ATP-
free torsin A is in the ER lumen. Disease-causing mutated torsin A is stably bound to 
LAP1 in the NE [118,119]. As a dilation of the perinuclear space was observed in 
patients, torsin accumulation may affect nuclear architecture, but it could also 
interfere with yet unknown functions of LAP1.  
 
Concluding comments and future directions 
Although we have much to discover about the functions of LAPs, their involvement 
in such a wide range of human diseases indicates that these functions are critical.  The 
plethora of functions already uncovered range from the mechanical integrity of the 
nucleus to genome organization and regulation of signaling. It will be essential in the 
future to identify and analyze tissue-specific LAP complexes and their functions.  
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Figure Legends: 
 Figure 1.  
 
Schematic representation of the nuclear envelope and potential transport mechanisms 
of membrane proteins to the inner nuclear membrane: the nuclear envelope (NE) is 
comprised of a double membrane system of outer (ONM) and inner (INM) nuclear 
membranes. The ONM is continuous with the endoplasmic reticulum (ER). Several 
integral membrane proteins are embedded in both ONM and INM. Many of those in 
the INM physically interact with the lamin polymer that underlies the INM (LAP, 
Lamina-associated polypeptides). Nuclear pore complexes (NPC) perforate the 
nuclear membrane where ONM and INM join and appear to be involved both in 
transport of soluble factors between the nucleus and cytoplasm through their inner 
channel and in transport of INM LAPs on their outer face. INM proteins may diffuse 
laterally along the membrane from the ER to the INM in an energy-dependent manner 
and are retained by interaction with the lamina (pathway 1). In theory, alternative 
pathways for INM protein transport into the nucleus include budding off of vesicles 
with the protein from the ONM and fusion with the INM (pathway 2); or release of 
the INM protein from ER membranes, transport through NPC by classical transport 
pathways and insertion into the INM (pathway 3). Pathways 2 and 3, however, are 
energetically unfavorable and have little or no support in the literature.  
 
Figure 2.  
 
Abundantly expressed LAPs can form tissue-specific complexes with different 
functions through (i) the availability of specific binding partners in specific tissues, 
(ii) the relative abundance of partners in tissues, and (iii) distinct binding affinities of 
partners. TM, transmembrane domain; A-D, LAP binding partners; number of 
connecting lines denote binding strength.  
 
Figure 3.  
 
Functions of LAP complexes: Lamin A/C-associated emerin, MAN1 (may also bind 
lamin B), and LEM 2 interact with BAF and may be involved in chromatin 
organization. Lamin B-associated LAP2β and LBR bind BAF and HP1, respectively 
and provide anchors for compacted heterochromatin (with H3K9-trimethyl marks). 
LAP2β also binds histone deacetylase HDAC3, which contributes to heterochromatin 
formation. Both types of complexes are also involved in nuclear architecture. SUN-
dimer/Nesprin complexes, interacting in the perinuclear space via their SUN and 
KASH domains, respectively, provide the link between the lamina and cytoplasmic 
actin and intermediate filaments (via plectin). In addition, emerin binds to the 
transcriptional repressors gcl and Btf and the transcription factor Lmo7, and LAP2β 
to gcl, and BAF to cone-rod homeobox protein Crx. Thus, these proteins may be 
involved in the regulation of gene expression. MAN1 antagonizes TGFβ signaling by 
binding Smads, and emerin binds to and impairs β-catenin transcriptional activity. 
Finally, nucleoplasmic lamin A/C-LAP2α complexes bind to BAF and Rb and thus 
affect chromatin organization and E2F/Rb and Rb/MyoD pathways, respectively. 
LAP2β may also affect the Rb pathway via gcl.  
 
 
Table 1 — Properties described for LAPs 
 
LAPs NE 
targeting 
Integral 
membrane 
protein 
Triton-
resistant 
Lamin 
binding 
Other 
LAP 
binding 
Lamins 
affect 
targeting 
LAPs at the nuclear 
periphery 
      
LAP1 + [10] + [10] + [10] A,B [9]  + [120] 
LBR + [36] + [36] + [36] B [36]  + 
[99,101] 
LAP2β + [9] + [9] + [9] B [9]  + [18] 
Emerin + [23] + [41] + [23] A 
[30,33,109] 
MAN1 
[32], 
Nesprin-
1-alpha 
[121], 
Nesprin-2 
[45] 
+ 
[34,122] 
MAN1 + [123] + [22] + [123] A,B [32] Emerin 
[32] 
+ [124] 
Nurim + [125] + [41] + [125] nt*  nt 
UNCL + [126] + [126]  + [126] nt  nt 
Syne/Myne/Nesprin-
1 
+ [127] + pred + [128] A [129] Emerin 
[121], 
SUN1 
[39] 
nt 
Syne/Nesprin-2 
alpha and beta 
+ {130] + pred + [45] A [45] Emerin 
[45], 
SUN1 
[39, 40] 
+ [45,46] 
Syne/Nesprin-2G** + [38] + pred nt nt SUN2 
[38] 
nt 
Nesprin-3/NET53** + [131] + [25] nt nt  nt 
Unc84A/SUN1 + [41] + [41] + [41] A [39]*** Nesprin 
1/2 
KASH 
domain 
[39, 40] 
- [38,39] 
SUN2 + [42] + [42] + [42] A [38] Nesprin 
2G [38] 
+ [38] 
LUMA + [41] + [41] + [41] nt  nt 
NET8 + [25] + pred + [25] nt  nt 
NET39 + [25] + [25] + [25] nt  nt 
NET51 + [25] + [25] + [25] nt  nt 
NET56 + [25] + pred + [25] nt  nt 
LEM2/NET25 + [24] + [24] + [24] A [24] LAP2-
alpha [24] 
+  [24] 
NET9 + [132] + pred + [132] nt  nt 
NET32 + [132] + pred + [132] nt  nt 
NET37 + [132] + [25] + [132] nt  nt 
Titin + 
[133]**** 
- [134] nt + [133,135]  nt**** 
Nup53 + [136] - [136] + [136] + [136]  nt 
SREBP-1 + [137] - [138] nt + [137,139]  + [137] 
c-Fos + [140] - [141] nt***** + [140]  + [140] 
       
LAPs in the 
nucleoplasm 
      
LAP2α - [19] - [16] + [19] A [20]  + [20] 
Lco1 - [142] - [142] nt****** + [142]  + [142] 
MOK2 - [143] - [144] + [145] + [145]  + [145] 
nt=not tested; pred=predicted. 
* It was suggested that nurim targets to the NE independent of lamin-binding as 
expressed protein failed to target to the NE in heterologous systems upon expression 
of lamins. However, only A-type lamins were tested and direct binding has yet to be 
examined. 
** Although not all Nesprin subtypes have been fully characterized yet, we define 
both proteins as LAPs, based on the properties reported for Nesprin-2 and the 
similarities between the two proteins. 
*** UNC84A was shown to bind lamins. However, NE localization of human 
UNC84A was recently shown to not depend upon binding to lamins [146]. 
**** In this study only a slight enrichment was observed at the NE for a fragment of 
human titin shown to bind lamins in a 2-hybrid screen [135], when fused to GFP 
[133]. However, this weak result was strengthened because in C. elegans the authors 
demonstrated a cell cycle-dependent strong targeting of Ce-titin to the NE that was 
dependent on lamins. 
***** Ectopic expression of lamin protected c-Fos from detergent solubilization, but 
NP-40 instead of Triton X-100 was used. 
****** Although resistance to Triton X-100 was not tested, binding affinity was high 
and reactions were performed in the presence of high salt; so a more stable interaction 
is indicated. 
 
 
Table 2 — LAPs linked to human diseases 
 
Mutated LAP Disease Phenotype Comments Reference 
Emerin Emery-Dreifuss 
muscular 
dystrophy 
Contractures of 
elbows, Achilles 
tendon, neck and 
spine. Progressive 
weakness in upper 
arms and lower 
limbs. Often 
associated with 
dilated 
cardiomyopathy. 
Other variants 
caused by lamin 
mutations 
[23,107,147] 
LAP2α Familial dilated 
cardiomyopathy 
Ventricular 
dilation and 
impaired cystolic 
function. Cardiac 
pump failure may 
occur after 
conduction 
abnormalities.  
Other variants 
caused by lamin 
mutations 
[114] 
LBR Pelger-Huet 
anomaly 
Neutrophil nuclei 
in heterozygotes 
have fewer 
segments and 
course chromatin, 
with no effects on 
normal health. 
Homozygotes 
have epilepsy and 
skeletal 
abnormalities. 
 [76] 
LBR Greenberg/HEM 
skeletal dysplasia 
Widespread tissue 
edema in fetus. 
Disorganized 
bone structure, 
short limbs and 
conversion of 
cartilage to bone. 
Early in utero 
lethality. 
 [116] 
MAN1/LEMD3 Buschke-
Ollendorff 
syndrome 
Skeletal defects 
include spots of 
increased bone 
density and 
sclerosis in a 
flowing pattern. 
Accompanied by 
joint contractures, 
skin lesions and 
muscle atrophy. 
 [115] 
Torsin A Torsion dystonia Prolonged, 
involuntary 
muscle 
contractions 
induce abnormal 
posture and 
twisting or 
repetitive 
TorsinA only 
accumulates at the 
NE when 
mutated, binds to 
LAP1 
[118, 119, 148] 
movements in 
arms and legs. 
SYNE1 Autosomal 
recessive 
cerebellar ataxia 
Impaired walking 
due to a lack of 
coordination of 
gait and limbs. 
Often also 
pyramidal 
features, 
peripheral 
neuropathy, 
cognitive loss or 
retinopathy. 
Mutation may 
affect a Syne 
variant not 
localized to the 
NE. 
[117] 
 
